Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
May 17, 2022
Comparison of three zinc binding groups for HDAC inhibitors - A potency, selectivity and enzymatic kinetics study
Kairui Yue, Mengting Qin, Chao Huang, et al.
European Journal of Medicinal Chemistry
|
August 30, 2023
Design, synthesis, and biological evaluation of novel HDAC/CD13 dual inhibitors for the treatment of cancer
Geng Jia, Kangjing Qi, Baogeng Hou, et al.
European Journal of Medicinal Chemistry
|
July 24, 2024
Design, synthesis, and biological activity evaluation of novel HDAC3 selective inhibitors for combination with Venetoclax against acute myeloid leukemia
Enqiang Liu, Yuxin Chen, Mengting Qin, et al.
Journal of Medicinal Chemistry
|
September 8, 2022
First-in-Class Hydrazide-Based HDAC6 Selective Inhibitor with Potent Oral Anti-Inflammatory Activity by Attenuating NLRP3 Inflammasome Activation
Kairui Yue, Simin Sun, Geng Jia, et al.
Bioorganic Chemistry
|
September 8, 2023
Discovery of new non-covalent and covalent inhibitors targeting SARS-CoV-2 papain-like protease and main protease
Wandong Liu, Juan Wang, Suyun Wang, et al.
Journal of Medicinal Chemistry
|
April 7, 2025
Development of Hydrazide-Based HDAC6 Selective Inhibitors for Treating NLRP3 Inflammasome-Related Diseases
Kairui Yue, Simin Sun, Zequn Yin, et al.
European Journal of Medicinal Chemistry
|
June 8, 2024
Psammaplin A analogues with modified disulfide bond targeting histone deacetylases: Synthesis and biological evaluation
Yukun Jiang, Ya Tang, Yuxuan Li, et al.
European Journal of Medicinal Chemistry
|
January 15, 2024
HDAC/NAMPT dual inhibitors overcome initial drug-resistance in p53-null leukemia cells
Kairui Yue, Simin Sun, Enqiang Liu, et al.
European Journal of Medicinal Chemistry
|
December 14, 2022
Synthesis and bioactivity evaluation of ferrocene-based hydroxamic acids as selective histone deacetylase 6 inhibitors
Jiangkun Yan, Kairui Yue, Xuejing Fan, et al.
Bioorganic Chemistry
|
October 4, 2022
1,2-Isoselenazol-3(2H)-one derivatives as NDM-1 inhibitors displaying synergistic antimicrobial effects with meropenem on NDM-1 producing clinical isolates
Kairui Yue, Chen Xu, Zhihao Wang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Bioorganic & Medicinal Chemistry Letters
|
May 17, 2022
Comparison of three zinc binding groups for HDAC inhibitors - A potency, selectivity and enzymatic kinetics study
Kairui Yue, Mengting Qin, Chao Huang, et al.
European Journal of Medicinal Chemistry
|
August 30, 2023
Design, synthesis, and biological evaluation of novel HDAC/CD13 dual inhibitors for the treatment of cancer
Geng Jia, Kangjing Qi, Baogeng Hou, et al.
European Journal of Medicinal Chemistry
|
July 24, 2024
Design, synthesis, and biological activity evaluation of novel HDAC3 selective inhibitors for combination with Venetoclax against acute myeloid leukemia
Enqiang Liu, Yuxin Chen, Mengting Qin, et al.
Journal of Medicinal Chemistry
|
September 8, 2022
First-in-Class Hydrazide-Based HDAC6 Selective Inhibitor with Potent Oral Anti-Inflammatory Activity by Attenuating NLRP3 Inflammasome Activation
Kairui Yue, Simin Sun, Geng Jia, et al.
Bioorganic Chemistry
|
September 8, 2023
Discovery of new non-covalent and covalent inhibitors targeting SARS-CoV-2 papain-like protease and main protease
Wandong Liu, Juan Wang, Suyun Wang, et al.
Journal of Medicinal Chemistry
|
April 7, 2025
Development of Hydrazide-Based HDAC6 Selective Inhibitors for Treating NLRP3 Inflammasome-Related Diseases
Kairui Yue, Simin Sun, Zequn Yin, et al.
European Journal of Medicinal Chemistry
|
June 8, 2024
Psammaplin A analogues with modified disulfide bond targeting histone deacetylases: Synthesis and biological evaluation
Yukun Jiang, Ya Tang, Yuxuan Li, et al.
European Journal of Medicinal Chemistry
|
January 15, 2024
HDAC/NAMPT dual inhibitors overcome initial drug-resistance in p53-null leukemia cells
Kairui Yue, Simin Sun, Enqiang Liu, et al.
European Journal of Medicinal Chemistry
|
December 14, 2022
Synthesis and bioactivity evaluation of ferrocene-based hydroxamic acids as selective histone deacetylase 6 inhibitors
Jiangkun Yan, Kairui Yue, Xuejing Fan, et al.
Bioorganic Chemistry
|
October 4, 2022
1,2-Isoselenazol-3(2H)-one derivatives as NDM-1 inhibitors displaying synergistic antimicrobial effects with meropenem on NDM-1 producing clinical isolates
Kairui Yue, Chen Xu, Zhihao Wang, et al.
Page
of 2